Updated: Wednesday 4 November 2026
- Zydus Lifesciences reported a net profit of ₹928 crore in Q2 FY27, 25.10% lower than a year earlier.
- Revenue from operations: ₹7,910 crore, 29.17% higher than a year earlier.
- Net profit margin: 11.73% (20.23% a year earlier).
- Shares: ₹1,188.10, −4.23% at 15:31 IST on 4 Nov 2026.
Zydus Lifesciences Q2 FY27 results show a net profit of ₹928 crore, which is 25.10% lower than a year earlier. The company filed these results on 4 November 2026 at 12:24 pm IST.
Revenue from operations for the quarter reached ₹7,910 crore. This figure is 29.17% higher than the same quarter a year ago.
Zydus Lifesciences Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| Revenue from operations | 7,910 | 6,123 | +29.17% | 8,017 | −1.34% |
| Profit before tax | 1,262 | 1,693 | −25.46% | 1,344 | −6.15% |
| Net profit | 928 | 1,239 | −25.10% | 990 | −6.31% |
| Earnings per share | ₹9.27 | ₹12.51 | −25.88% | ₹9.42 | −1.52% |
| Net profit as a share of revenue | 11.73% | 20.23% | – | 12.35% | – |
The company reported a profit before tax of ₹1,262 crore for the quarter. Net profit as a share of revenue was 11.73%, compared to 20.23% in Q2 FY26 and 12.35% in Q1 FY27. For the half-year ending 30 September 2026, the company recorded a net profit of ₹1,939 crore, which is 29.75% lower than the same period a year earlier.
Zydus Lifesciences half-year figures
| ₹ crore | Half-year | Same period a year earlier | Change |
|---|---|---|---|
| Revenue from operations | 15,927 | 12,697 | +25.44% |
| Net profit | 1,939 | 2,760 | −29.75% |
Zydus Lifesciences share price after the results
| Share price (15:31 IST) | ₹1,188.10 |
| Previous close | ₹1,240.60 |
| Change | −₹52.50 (−4.23%) |
| Nifty Pharma | +0.42% |
| Nifty 50 | +0.63% |
The share price of Zydus Lifesciences Ltd. closed at ₹1,188.10 on 4 November 2026. This represents a move of −4.23% from the previous close of ₹1,240.60. The company filed its results at 12:24 pm IST during the trading session.
How Zydus Lifesciences shares moved on its earlier results
| Quarter | Results filed | Window | Change |
|---|---|---|---|
| Q1 FY27 | 11 Aug 2026 | 10 Aug 2026 to 11 Aug 2026 | +6.43% |
| Q4 FY26 | 19 May 2026 | 18 May 2026 to 19 May 2026 | +2.80% |
The share price moved by +6.43% between 10 August 2026 and 11 August 2026 for Q1 FY27. The stock price moved by +2.80% between 18 May 2026 and 19 May 2026 for Q4 FY26.
Zydus Lifesciences Q2 FY27 results: FAQs
What were Zydus Lifesciences’s Q2 FY27 results?
Zydus Lifesciences reported a net profit of ₹928 crore and revenue from operations of ₹7,910 crore for the quarter ended 30 September 2026 (consolidated figures). Net profit was 25.10% lower than a year earlier and revenue from operations was 29.17% higher than a year earlier.
When did Zydus Lifesciences announce its Q2 FY27 results?
The results were filed with the exchange at Wed 4 Nov, 12:24 pm IST.
What was Zydus Lifesciences’s net profit margin in Q2 FY27?
Net profit was 11.73% of revenue, against 20.23% in the same quarter a year earlier.
What is the Zydus Lifesciences share price after the results?
₹1,188.10, −4.23% from the previous close of ₹1,240.60, at 15:31 IST on Wednesday 4 November 2026. The results were filed at 12:24 IST, during the session; the move is from the previous close, so it includes trading before the filing.
Results are the company’s filings to the exchanges; prices are from the National Stock Exchange. Calculations are by ThePip. For information only; not investment advice.